ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CNTB Connect Biopharma Holdings Inc

1.60
-0.08 (-4.76%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 26,214
Bid Price 1.60
Ask Price 1.75
News -
Share Name Share Symbol Market Stock Type
Connect Biopharma Holdings Inc CNTB NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.08 -4.76% 1.60 15:14:48
Open Price Low Price High Price Close Price Previous Close
1.79 1.53 1.79 1.60 1.68
Trades Shares Traded VWAP Financial Volume Average Volume
167 26,214  1.67  43,805 -
Last Trade Type Quantity Price Currency
18:46:35 2  1.60 USD

Connect Biopharma Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 1.58M -59.5M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Connect Biopharma

Date Time Source Heading
6/12/202415:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/27/202420:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
2/13/202415:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial..
2/13/202415:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202415:18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202415:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202305:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/21/202305:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/202314:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/20/202315:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/202315:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/202305:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CNTB Message Board. Create One! See More Posts on CNTB Message Board See More Message Board Posts

CNTB Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233.